Latest news
Merck gets $9.5bn underwritten facility for Bio-Techne acquisition - Global CapitalGlobal Capital · Fri, 31 Jul 2026 14:45:29 GMTINmune Bio Receives R&D Rebates of Approximately $4.6 Million - The Manila TimesThe Manila Times · Fri, 31 Jul 2026 11:20:58 GMTAB2 Bio gets $30M from Nippon Shinyaku for U.S. rights to Tadekinig alfa treating rare hyperinflammatory syndrome - PluangPluang · Thu, 30 Jul 2026 07:19:23 GMTAB2 Bio Gets $30 Mln From Nippon Shinyaku For U.S. Rights To Tadekinig Alfa - TradingViewTradingView · Thu, 30 Jul 2026 06:51:00 GMTAB2 Bio receives $30 million from Nippon Shinyaku for exclusive U.S. commercialization rights to Tadekinig Alfa - The Manila TimesThe Manila Times · Thu, 30 Jul 2026 06:37:58 GMTTevogen Bio Holdings Inc. Becomes Tevogen Inc. - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTUAE Gives ANKTIVA World’s First Approval Across BCG-Unresponsive Bladder Cancer - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMTWild Bio takes on Big Seed with acquisition of UK wheat breeder - agnavigator.comagnavigator.com · Tue, 28 Jul 2026 07:00:00 GMT